Tapewire

Nasdaq · USD

CCCC

C4 Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5503
SEC CIK
0001662579
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 5, 2026 21:10 UTC GrantCommon Stock 5,958 $1.93 $11,498.94
Disclosure

SEC source: 0001470831-26-000009 · wk-form4_1767647442.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,532

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 21:10 UTC GrantCommon Stock 7,513 $1.93 $14,500.09
Disclosure

SEC source: 0001470831-26-000008 · wk-form4_1767647408.xml · nonDerivative · entry 1

GROGAN DONNA ROY · CIK 0001788455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,142

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 16:30 UTC
Mahaney PaigeChief Scientific Officer
Tax withholdingCommon Stock 5,644 $2.58 $14,561.52
Disclosure

SEC source: 0001193125-25-258664 · ownership.xml · nonDerivative · entry 2

Mahaney Paige · CIK 0002040313 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,356

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
October 28, 2025 Filed Oct 30, 2025 16:30 UTC
Mahaney PaigeChief Scientific Officer
Exercise / conversionCommon Stock 19,200 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-258664 · ownership.xml · nonDerivative · entry 1

Mahaney Paige · CIK 0002040313 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:14 UTC GrantCommon Stock 5,349 $2.15 $11,500.35
Disclosure

SEC source: 0001470831-25-000250 · wk-form4_1759522454.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,574

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:13 UTC GrantCommon Stock 6,740 $2.15 $14,491.00
Disclosure

SEC source: 0001470831-25-000249 · wk-form4_1759522434.xml · nonDerivative · entry 1

GROGAN DONNA ROY · CIK 0001788455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,629

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025.

Read SEC document
September 18, 2025 Filed Sep 19, 2025 16:13 UTC
Adams KendraChief Financial Officer
Tax withholdingCommon Stock 2,775 $3.32 $9,213.00
Disclosure

SEC source: 0001470831-25-000223 · wk-form4_1758312827.xml · nonDerivative · entry 2

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,342

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
September 18, 2025 Filed Sep 19, 2025 16:13 UTC
Adams KendraChief Financial Officer
Exercise / conversionCommon Stock 6,250 $0.00 $0.00
Disclosure

SEC source: 0001470831-25-000223 · wk-form4_1758312827.xml · nonDerivative · entry 1

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,117

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023.

Read SEC document
July 10, 2025 Filed Jul 14, 2025 20:19 UTC
REYNO LEONARDChief Medical Officer
Tax withholdingCommon Stock 7,382 $1.99 $14,690.18
Disclosure

SEC source: 0001662579-25-000055 · wk-form4_1752524362.xml · nonDerivative · entry 1

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,382

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
July 10, 2025 Filed Jul 15, 2025 13:00 UTC Amendment
REYNO LEONARDChief Medical Officer
Tax withholdingCommon Stock 7,382 $1.99 $14,690.18
Disclosure

SEC source: 0001662579-25-000057 · wk-form4a_1752584408.xml · nonDerivative · entry 2

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,382

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
July 10, 2025 Filed Jul 15, 2025 13:00 UTC Amendment
REYNO LEONARDChief Medical Officer
Exercise / conversionCommon Stock 15,325 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000057 · wk-form4a_1752584408.xml · nonDerivative · entry 1

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 20:17 UTC GrantCommon Stock 7,616 $1.51 $11,500.16
Disclosure

SEC source: 0001662579-25-000053 · wk-form4_1751487429.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,225

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 20:17 UTC GrantCommon Stock 9,609 $1.51 $14,509.59
Disclosure

SEC source: 0001662579-25-000052 · wk-form4_1751487418.xml · nonDerivative · entry 1

GROGAN DONNA ROY · CIK 0001788455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,889

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:11 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000047 · wk-form4_1750450293.xml · derivative · entry 1

Fawell Stephen · CIK 0002033387 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:11 UTC
Hughes OwenDirector
GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000048 · wk-form4_1750450303.xml · derivative · entry 1

Hughes Owen · CIK 0001575933 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:10 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000042 · wk-form4_1750450241.xml · derivative · entry 1

Hoerter Steven L. · CIK 0001533451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:12 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000049 · wk-form4_1750450313.xml · derivative · entry 1

Koppikar Utpal · CIK 0001742696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:11 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000046 · wk-form4_1750450283.xml · derivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:11 UTC
Bessen LauraDirector
GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000045 · wk-form4_1750450270.xml · derivative · entry 1

Bessen Laura · CIK 0001926815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:11 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000044 · wk-form4_1750450260.xml · derivative · entry 1

GROGAN DONNA ROY · CIK 0001788455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
June 18, 2025 Filed Jun 20, 2025 20:10 UTC GrantStock Option (Right to Buy) · Derivative 35,500 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001662579-25-000043 · wk-form4_1750450250.xml · derivative · entry 1

Cooper Ronald Harold Wilfred · CIK 0001676880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 35,500 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:11 UTC GrantCommon Stock 9,581 $1.44 $13,748.74
Disclosure

SEC source: 0001662579-25-000025 · wk-form4_1743711105.xml · nonDerivative · entry 1

GROGAN DONNA ROY · CIK 0001788455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,280

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:11 UTC GrantCommon Stock 7,841 $1.44 $11,251.84
Disclosure

SEC source: 0001662579-25-000024 · wk-form4_1743711094.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,609

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025.

Read SEC document
February 18, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
SaleCommon Stock 669 $3.15 $2,107.35
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 5

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,805

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024.

Read SEC document
February 15, 2025 Filed Feb 18, 2025 21:55 UTC
Hirsch AndrewDirector · President & CEO
Tax withholdingCommon Stock 9,370 $3.18 $29,796.60
Disclosure

SEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 3

Hirsch Andrew · CIK 0001586707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 423,145

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
GrantStock Option (Right to Buy) · Derivative 84,700 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · derivative · entry 6

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,700

Underlying: Common Stock · 84,700 shares

Expires 2035-02-13

F4 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
Tax withholdingCommon Stock 2,368 $3.18 $7,530.24
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 4

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,474

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
SaleCommon Stock 490 $3.15 $1,543.50
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 3

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,842

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
GrantCommon Stock 56,500 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 2

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,332

F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:54 UTC
Mahaney PaigeChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 42,400 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000015 · wk-form4_1739915672.xml · derivative · entry 2

Mahaney Paige · CIK 0002040313 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,400

Underlying: Common Stock · 42,400 shares

Expires 2035-02-13

F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:54 UTC
Mahaney PaigeChief Scientific Officer
GrantCommon Stock 28,200 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000015 · wk-form4_1739915672.xml · nonDerivative · entry 1

Mahaney Paige · CIK 0002040313 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Mossler MarkChief Accounting Officer
Tax withholdingCommon Stock 1,586 $3.18 $5,043.48
Disclosure

SEC source: 0001662579-25-000018 · wk-form4_1739915700.xml · nonDerivative · entry 1

Mossler Mark · CIK 0001992219 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,204

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:54 UTC
Adams KendraChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 130,600 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · derivative · entry 4

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,600

Underlying: Common Stock · 130,600 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:54 UTC
Adams KendraChief Financial Officer
Tax withholdingCommon Stock 4,559 $3.18 $14,497.62
Disclosure

SEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 3

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,117

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 16:54 UTC
Adams KendraChief Financial Officer
GrantCommon Stock 87,100 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 2

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,676

F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
REYNO LEONARDChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 130,600 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · derivative · entry 3

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,600

Underlying: Common Stock · 130,600 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
REYNO LEONARDChief Medical Officer
Tax withholdingCommon Stock 5,145 $3.18 $16,361.10
Disclosure

SEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · nonDerivative · entry 2

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,764

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
REYNO LEONARDChief Medical Officer
GrantCommon Stock 87,100 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · nonDerivative · entry 1

REYNO LEONARD · CIK 0001528716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,909

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Hirsch AndrewDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 335,300 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · derivative · entry 4

Hirsch Andrew · CIK 0001586707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,300

Underlying: Common Stock · 335,300 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Hirsch AndrewDirector · President & CEO
Tax withholdingCommon Stock 12,847 $3.18 $40,853.46
Disclosure

SEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 2

Hirsch Andrew · CIK 0001586707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 432,515

F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Hirsch AndrewDirector · President & CEO
GrantCommon Stock 223,500 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 1

Hirsch Andrew · CIK 0001586707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 445,362

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Siegel JolieChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 84,700 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · derivative · entry 4

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,700

Underlying: Common Stock · 84,700 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Siegel JolieChief Legal Officer
Tax withholdingCommon Stock 2,914 $3.18 $9,266.52
Disclosure

SEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 3

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,939

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:55 UTC
Siegel JolieChief Legal Officer
GrantCommon Stock 56,500 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 2

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,853

F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
Schick KellyChief People Officer
GrantStock Option (Right to Buy) · Derivative 84,700 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · derivative · entry 4

Schick Kelly · CIK 0001797388 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,700

Underlying: Common Stock · 84,700 shares

Expires 2035-02-13

F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
Schick KellyChief People Officer
Tax withholdingCommon Stock 2,368 $3.18 $7,530.24
Disclosure

SEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · nonDerivative · entry 3

Schick Kelly · CIK 0001797388 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,885

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 21:54 UTC
Schick KellyChief People Officer
GrantCommon Stock 56,500 $0.00 $0.00
Disclosure

SEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · nonDerivative · entry 2

Schick Kelly · CIK 0001797388 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,253

F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 16:55 UTC
Boyle Scott NChief Business Officer
Tax withholdingCommon Stock 1,735 $3.20 $5,552.00
Disclosure

SEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 1

Boyle Scott N · CIK 0001913897 · Chief Business Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,832

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 16:54 UTC
Adams KendraChief Financial Officer
Tax withholdingCommon Stock 1,863 $3.20 $5,961.60
Disclosure

SEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 1

Adams Kendra · CIK 0001991929 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,576

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:55 UTC
Siegel JolieChief Legal Officer
Tax withholdingCommon Stock 2,135 $3.20 $6,832.00
Disclosure

SEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 1

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,353

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.